218 related articles for article (PubMed ID: 30104217)
1. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Shah UA; Chung EY; Giricz O; Pradhan K; Kataoka K; Gordon-Mitchell S; Bhagat TD; Mai Y; Wei Y; Ishida E; Choudhary GS; Joseph A; Rice R; Gitego N; Parrish C; Bartenstein M; Goel S; Mantzaris I; Shastri A; Derman O; Binder A; Gritsman K; Kornblum N; Braunschweig I; Bhagat C; Hall J; Graber A; Ratner L; Wang Y; Ogawa S; Verma A; Ye BH; Janakiram M
Blood; 2018 Oct; 132(14):1507-1518. PubMed ID: 30104217
[TBL] [Abstract][Full Text] [Related]
2. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract][Full Text] [Related]
3. ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent.
Luchtel RA; Zhao Y; Aggarwal RK; Pradhan K; Maqbool SB
Blood Adv; 2022 Oct; 6(20):5613-5624. PubMed ID: 35675522
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Hatta Y; Koeffler HP
Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
[TBL] [Abstract][Full Text] [Related]
5. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
6. Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma.
Yoshida N; Imaizumi Y; Utsunomiya A; Miyoshi H; Arakawa F; Tsukasaki K; Ohshima K; Seto M
J Clin Exp Hematop; 2015; 55(1):13-6. PubMed ID: 26106001
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.
Morichika K; Karube K; Kayo H; Uchino S; Nishi Y; Nakachi S; Okamoto S; Morishima S; Ohshiro K; Nakazato I; Fukushima T; Masuzaki H
Cancer Sci; 2019 Sep; 110(9):2982-2991. PubMed ID: 31237072
[TBL] [Abstract][Full Text] [Related]
8. Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia/lymphoma (ATLL) in US/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy.
Yao J; Gottesman SR; Ayalew G; Braverman AS; Axiotis CA
Am J Surg Pathol; 2013 Sep; 37(9):1407-12. PubMed ID: 23797717
[TBL] [Abstract][Full Text] [Related]
9. Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer: a clinical and translational study.
Wang H; Wang Z; Wang Z; Li X; Li Y; Yan N; Wu L; Liang Y; Wu J; Song H; Qu Q; Huang J; Chang C; Shen K; Chen X; Lu M
Front Med; 2024 Apr; 18(2):357-374. PubMed ID: 38157193
[TBL] [Abstract][Full Text] [Related]
10. Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
Nagata Y; Kontani K; Enami T; Kataoka K; Ishii R; Totoki Y; Kataoka TR; Hirata M; Aoki K; Nakano K; Kitanaka A; Sakata-Yanagimoto M; Egami S; Shiraishi Y; Chiba K; Tanaka H; Shiozawa Y; Yoshizato T; Suzuki H; Kon A; Yoshida K; Sato Y; Sato-Otsubo A; Sanada M; Munakata W; Nakamura H; Hama N; Miyano S; Nureki O; Shibata T; Haga H; Shimoda K; Katada T; Chiba S; Watanabe T; Ogawa S
Blood; 2016 Feb; 127(5):596-604. PubMed ID: 26574607
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
13. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Shah UA; Shah N; Qiao B; Acuna-Villaorduna A; Pradhan K; Adrianzen Herrera D; Sica RA; Shastri A; Mantzaris I; Derman O; Kornblum N; Braunschweig I; Ye BH; Verma A; Janakiram M
Cancer; 2020 Feb; 126(3):567-574. PubMed ID: 31769871
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin.
Levine PH; Jaffe ES; Manns A; Murphy EL; Clark J; Blattner WA
Yale J Biol Med; 1988; 61(3):215-22. PubMed ID: 3262954
[TBL] [Abstract][Full Text] [Related]
16. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M
Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
18. Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina.
Marin O; Hasui K; Remondegui C; Sato E; Aye MM; Takenouchi N; Izumo S; Tajima K
Pathol Int; 2002; 52(5-6):348-57. PubMed ID: 12100517
[TBL] [Abstract][Full Text] [Related]
19. Acetyl transferase EP300 deficiency leads to chronic replication stress mediated by defective fork protection at stalled replication forks.
Barreto-Galvez A; Niljikar M; Gagliardi J; Zhang R; Kumar V; Juruwala A; Pradeep A; Shaikh A; Tiwari P; Sharma K; Gerhardt J; Cao J; Kataoka K; Durbin A; Qi J; Ye BH; Madireddy A
bioRxiv; 2023 Apr; ():. PubMed ID: 37163075
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
